You are here
ZoneOne Pharma
http://www.zoneonepharma.com
UEI: Q19PXJ661KK3
# of Employees: 4
HUBZone Owned: Yes
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Non-irritating Sustained Release Cysteamine Eye Drops to Treat Cystinosis
Amount: $238,466.00ABSTRACT The project goal is to develop a non irritating treatment for cystinosis induced corneal cystine crystal accumulation that can be administered approximately every hours Cystinosis is a rar ...
SBIRPhase I2016Department of Health and Human Services National Institutes of Health -
Twice-Weekly Subcutaneous Liposome Chelator to Treat Transfusional Iron Overload
Amount: $1,491,193.00DESCRIPTION provided by applicant We have devised a novel stable nanoliposome encapsulated desferoxamine DFO formulation LDFO for the treatment of iron overload Data from a pre clinical model ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
Retargeting FDA Approved Anticancer Liposomal Drugs to Cancer Stem Cells
Amount: $298,920.00DESCRIPTION provided by applicant The goal of this research is to develop a ligand product and facile method to use it to target FDA approved liposomal anticancer drugs to cancer stem cells that ov ...
STTRPhase I2015Department of Health and Human Services National Institutes of Health -
Twice-Weekly Subcutaneous Liposome Chelator to Treat Transfusional Iron Overload
Amount: $160,664.00DESCRIPTION (provided by applicant): About 100,000 babies are born each year with severe thalassemia type blood disorders or sickle cell anemia, leading to a lifelong regime of blood transfusions. How ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health -
OTHER FUNCTIONS- RandD BIOMEDICAL (BASIC RESEARCH)
Amount: $215,999.00The Hsp90 inhibitor 17-DMAG will be encapsulated in a nano-sized liposome formulation that is long-circulating with controlled drug release properties in tumor tissue. Reformulation of 17-DMAG in a na ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health